Publications: Mr Edward Carter
Wilcz-Villega E, Carter E, Ironside A, Xu R, Mataloni I, Holdsworth J, Jones W, Moreno Béjar R et al.(2020).
Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway. EMBO Molecular Medicine
vol. 12,
(2)
Pedrosa A-R, BODRUG N, Gomez-Escudero J, Carter EP, Reynolds LE, Georgiou PN, Fernandez I, Lees DM et al.(2019).
Tumour angiogenesis is differentially regulated by endothelial cell Focal Adhesion Kinase tyrosine-397 and -861 phosphorylation. Cancer Research
Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker AM, Kapitonova E, Bakhouche BA, Tanner Y et al.(2018).
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Reports
vol. 22,
(9)
2469-2481.
Clayton NS, Wilson AS, Laurent EP, Grose RP, Carter EP(2017).
Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment. Dev Dyn
vol. 246,
(7)
493-501.
Carter EP, Gopsill JA, Gomm JJ, Jones JL, Grose RP(2017).
A 3D in vitro model of the human breast duct: A method to unravel myoepithelial-luminal interactions in the progression of breast cancer. Breast Cancer Research
vol. 19,
(1)
Carter E, Gomm JJ, Jones LJ, Grose RP (2016).
A 3D in vitro model of the human breast duct: unravelling myoepithelial-luminal interactions in breast cancer. Breast Cancer Research and Treatment.
Conference: UK Breast Cancer Research Symposium 2016
vol. 159,
187-188.
Carter EP, Fearon AE, Grose RP(2015).
Careless talk costs lives: Fibroblast growth factor receptor signalling and the consequences of pathway malfunction. Trends in Cell Biology
vol. 25,
(4)
221-233.
